Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
Data Policies
IMAGES IN PNEUMONOLOGY
The unexpected clinical behavior of a-PAP
| 1 | 2nd Pulmonary Medicine Department,
General University Hospital "Attikon",
Medical School, National and Kapodistrian
University of Athens |
| 2 | Department of Respiratory Medicine, Faculty
of Medicine, School of Health Sciences,
University of Thessaly, Larissa |
| 3 | 2nd Department of Radiology, General
University Hospital "Attikon", Medical School,
National and Kapodistrian University
of Athens, Greece |
| 4 | Department of Pediatric Pneumology,
Dr von Hauner Children's Hospital, Ludwig-Maximilians-University, German Center for
Lung Research, Germany |
CORRESPONDING AUTHOR
Spyros A. Papiris
2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece 1 Rimini Street, 12462, Haidari, Greece
2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece 1 Rimini Street, 12462, Haidari, Greece
Pneumon 2020;33(2):1–2
KEYWORDS
This is to certify that the images have not been previously published and that the authors have no conflictof interest.
REFERENCES (6)
1.
Kumar A, Abdelmalak B, Inoue Y, Culver DA. Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach. Lancet Respir Med 2018, 6:554-65.
2.
Papiris SA, Tsirigotis P, Kolilekas L, et al. Pulmonary Alveolar Proteinosis: Time to shift. Expert Rev Respir Med 2015, 9:337-49.
3.
Oda N, Tamai K, Suzuki Y, et al. Marked improvement in autoimmune pulmonary alveolar proteinosis with severe hypoxemia in a patient treated with ambroxol: a case report. J Med Case Rep 2015, 9:100.
4.
Hashizume T. Pulmonary alveolar proteinosis successfully treated with ambroxol. Intern Med 2002, 41:1175-8.
5.
Diaz JP, Manresa Presas F, et al. Response to surfactant activator (ambroxol) in alveolar proteinosis. Lancet 1984, 1(8384):1023.
6.
Papiris SA, Tsirigotis P, Kolilekas L, et al. Autoimmune pulmonary alveolar proteiniosis: “The sleeping beauty and the kissing Drug”. Pneumon 2014, 27:200-201.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.